Skip to main content
Fig. 2 | Diabetology & Metabolic Syndrome

Fig. 2

From: Estimates and trends of the global burden of NASH-related liver cancer attributable to high fasting plasma glucose in 1990–2019: analysis of data from the 2019 Global Burden of Disease Study

Fig. 2

Temporal trend in the deaths, DALYs, YLDs, and YLLs rate of NASH-related liver cancer attributable to HFPG for different SDI regions, 1990–2019. NASH: non-alcoholic fatty liver disease; SDI: socio-demographic index; HFPG: high fasting plasma glucose; ASR, age-standardized rate; DALYs, disability adjusted life years; YLLs: Years of Life Lost; YLDs: Years Lived with Disability; NASH: nonalcoholic steatohepatitis

Back to article page